AFP and hepatocellular carcinoma: Through comprehensive assessment of AFP levels across cfDNA and CTCs, this study establishes a multimodal liquid biopsy approach that enhances the diagnostic precision and real-time monitoring of HCC, offering a clinically translatable strategy for advancing personalized oncology.